Neutralization assays constitute the definitive means to quantify the functional capacity of antibodies to inhibit SARS-CoV-2 entry into host cells. By assessing how serum or monoclonal antibodies ...

In a recent study published on the medRxiv* preprint server, researchers validate a quick, highly efficient, and automated assay to detect neutralizing antibodies (nAb) against the severe acute ...

Biomedical research faces a ubiquitous and fundamental challenge: Because the goal of the research is to improve human health, the human body is logically the best place to perform experiments.

Mutations of virus and illnesses caused by new variants are still to be expected even in a SARS-CoV-2 situation that has now become endemic. Although the population has developed specific immune ...

In a recent study posted to bioRxiv*, researchers evaluated how angiotensin-converting enzyme 2 (ACE2) expression in target cells impacts neutralization. Study: Receptor binding domain (RBD) ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Bio-Plex™ Pro Human SARS-CoV-2 Variant ...

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533 Vaccine-induced nAbs are detectable at much lower rates ...

Panel A shows spike protein sequences for the omicron BA.2, BA.2.75.2, XBB.1, BA.5, BF.7, and BQ.1.1 subvariants; mutations as compared with the WA1/2020 spike protein are shown. Mutations as compared ...

The US Food and Drug Administration (FDA) on Wednesday finalized guidance to help industry develop and validate immune assays for the assessment of the immunogenicity of therapeutic protein products ...